Serum testosterone concentrations are not associated with frailty in naturally ageing and testosterone-deficient older C57Bl/6 mice

Mech Ageing Dev. 2022 Apr:203:111638. doi: 10.1016/j.mad.2022.111638. Epub 2022 Feb 3.

Abstract

This study investigated how serum testosterone related to frailty in ageing male C57Bl/6 mice with or without lifelong testosterone deficiency. Mice underwent a sham surgery (n = 10) or gonadectomy (n = 11, GDX) at 4-weeks and then aged. Frailty scores (31-item frailty index) and testosterone were measured between 18- to 24-months of age. Age predicted frailty (p < 0.0001), but serum testosterone did not (p = 0.357). Life expectancy (AFRAID clock) and biologic age (FRIGHT clock) were not significantly different between groups (p = 0.485 and 0.142). The fact that lifelong testosterone deficiency did not exacerbate frailty suggests that low testosterone alone does not potently drive frailty in males.

Keywords: AFRAID clock; Ageing; Animal model; FRIGHT clock; Hormones.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging
  • Animals
  • Frailty*
  • Life Expectancy
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Testosterone

Substances

  • Testosterone